BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 33414170)

  • 1. Targeting Leukemia-Initiating Cells in Acute Lymphoblastic Leukemia.
    Tamiro F; Weng AP; Giambra V
    Cancer Res; 2021 Aug; 81(16):4165-4173. PubMed ID: 33414170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of CD34 and CD7 on human T-cell acute lymphoblastic leukemia discriminates functionally heterogeneous cell populations.
    Gerby B; Clappier E; Armstrong F; Deswarte C; Calvo J; Poglio S; Soulier J; Boissel N; Leblanc T; Baruchel A; Landman-Parker J; Roméo PH; Ballerini P; Pflumio F
    Leukemia; 2011 Aug; 25(8):1249-58. PubMed ID: 21566655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of CD34+ and CD34- leukemia-initiating cells in MLL-rearranged human acute lymphoblastic leukemia.
    Aoki Y; Watanabe T; Saito Y; Kuroki Y; Hijikata A; Takagi M; Tomizawa D; Eguchi M; Eguchi-Ishimae M; Kaneko A; Ono R; Sato K; Suzuki N; Fujiki S; Koh K; Ishii E; Shultz LD; Ohara O; Mizutani S; Ishikawa F
    Blood; 2015 Feb; 125(6):967-80. PubMed ID: 25538041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-Derived Bone Marrow Spheroids Reveal Leukemia-Initiating Cells Supported by Mesenchymal Hypoxic Niches in Pediatric B-ALL.
    Balandrán JC; Dávila-Velderrain J; Sandoval-Cabrera A; Zamora-Herrera G; Terán-Cerqueda V; García-Stivalet LA; Limón-Flores JA; Armenta-Castro E; Rodríguez-Martínez A; Leon-Chavez BA; Vallejo-Ruiz V; Hassane DC; Pérez-Tapia SM; Ortiz-Navarrete V; Guzman ML; Pelayo R
    Front Immunol; 2021; 12():746492. PubMed ID: 34737747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive feedback between NF-κB and TNF-α promotes leukemia-initiating cell capacity.
    Kagoya Y; Yoshimi A; Kataoka K; Nakagawa M; Kumano K; Arai S; Kobayashi H; Saito T; Iwakura Y; Kurokawa M
    J Clin Invest; 2014 Feb; 124(2):528-42. PubMed ID: 24382349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the MYC and PI3K pathways eliminates leukemia-initiating cells in T-cell acute lymphoblastic leukemia.
    Schubbert S; Cardenas A; Chen H; Garcia C; Guo W; Bradner J; Wu H
    Cancer Res; 2014 Dec; 74(23):7048-59. PubMed ID: 25287161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Notch1 inhibition targets the leukemia-initiating cells in a Tal1/Lmo2 mouse model of T-ALL.
    Tatarek J; Cullion K; Ashworth T; Gerstein R; Aster JC; Kelliher MA
    Blood; 2011 Aug; 118(6):1579-90. PubMed ID: 21670468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The circadian clock circuitry modulates leukemia initiating cell activity in T-cell acute lymphoblastic leukemia.
    Murgo E; De Santis E; Sansico F; Melocchi V; Colangelo T; Padovano C; Colucci M; Carbone A; Totti B; Basti A; Gottschlich L; Relogio A; Capitanio N; Bianchi F; Mazzoccoli G; Giambra V
    J Exp Clin Cancer Res; 2023 Aug; 42(1):218. PubMed ID: 37620852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parthenolide eliminates leukemia-initiating cell populations and improves survival in xenografts of childhood acute lymphoblastic leukemia.
    Diamanti P; Cox CV; Moppett JP; Blair A
    Blood; 2013 Feb; 121(8):1384-93. PubMed ID: 23264600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxic, glycolytic metabolism is a vulnerability of B-acute lymphoblastic leukemia-initiating cells.
    Morris V; Wang D; Li Z; Marion W; Hughes T; Sousa P; Harada T; Sui SH; Naumenko S; Kalfon J; Sensharma P; Falchetti M; Vinicius da Silva R; Candelli T; Schneider P; Margaritis T; Holstege FCP; Pikman Y; Harris M; Stam RW; Orkin SH; Koehler AN; Shalek AK; North TE; Pimkin M; Daley GQ; Lummertz da Rocha E; Rowe RG
    Cell Rep; 2022 Apr; 39(4):110752. PubMed ID: 35476984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A niche-like culture system allowing the maintenance of primary human acute myeloid leukemia-initiating cells: a new tool to decipher their chemoresistance and self-renewal mechanisms.
    Griessinger E; Anjos-Afonso F; Pizzitola I; Rouault-Pierre K; Vargaftig J; Taussig D; Gribben J; Lassailly F; Bonnet D
    Stem Cells Transl Med; 2014 Apr; 3(4):520-9. PubMed ID: 24493855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NOTCH1 signaling promotes human T-cell acute lymphoblastic leukemia initiating cell regeneration in supportive niches.
    Ma W; Gutierrez A; Goff DJ; Geron I; Sadarangani A; Jamieson CA; Court AC; Shih AY; Jiang Q; Wu CC; Li K; Smith KM; Crews LA; Gibson NW; Deichaite I; Morris SR; Wei P; Carson DA; Look AT; Jamieson CH
    PLoS One; 2012; 7(6):e39725. PubMed ID: 22768113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-7R is essential for leukemia-initiating cell activity of T-cell acute lymphoblastic leukemia.
    González-García S; Mosquera M; Fuentes P; Palumbo T; Escudero A; Pérez-Martínez A; Ramírez M; Corcoran AE; Toribio ML
    Blood; 2019 Dec; 134(24):2171-2182. PubMed ID: 31530562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting signaling pathways in T-cell acute lymphoblastic leukemia initiating cells.
    Martelli AM; Lonetti A; Buontempo F; Ricci F; Tazzari PL; Evangelisti C; Bressanin D; Cappellini A; Orsini E; Chiarini F
    Adv Biol Regul; 2014 Sep; 56():6-21. PubMed ID: 24819383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noncanonical β-catenin interactions promote leukemia-initiating activity in early T-cell acute lymphoblastic leukemia.
    Panelli P; De Santis E; Colucci M; Tamiro F; Sansico F; Miroballo M; Murgo E; Padovano C; Gusscott S; Ciavarella M; Chavez EA; Bianchi F; Rossi G; Carella AM; Steidl C; Weng AP; Giambra V
    Blood; 2023 Mar; 141(13):1597-1609. PubMed ID: 36315912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intra-heterogeneity in transcription and chemoresistant property of leukemia-initiating cells in murine Setd2
    Song J; Du L; Liu P; Wang F; Zhang B; Xie Y; Lu J; Jin Y; Zhou Y; Lv G; Zhang J; Chen S; Chen Z; Sun X; Zhang Y; Huang Q
    Cancer Commun (Lond); 2021 Sep; 41(9):867-888. PubMed ID: 34196511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse xenograft modeling of human adult acute lymphoblastic leukemia provides mechanistic insights into adult LIC biology.
    Patel B; Dey A; Castleton AZ; Schwab C; Samuel E; Sivakumaran J; Beaton B; Zareian N; Zhang CY; Rai L; Enver T; Moorman AV; Fielding AK
    Blood; 2014 Jul; 124(1):96-105. PubMed ID: 24825861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The IL-2/CD25 axis maintains distinct subsets of chronic myeloid leukemia-initiating cells.
    Kobayashi CI; Takubo K; Kobayashi H; Nakamura-Ishizu A; Honda H; Kataoka K; Kumano K; Akiyama H; Sudo T; Kurokawa M; Suda T
    Blood; 2014 Apr; 123(16):2540-9. PubMed ID: 24574458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Notch1 gene mutations target KRAS G12D-expressing CD8+ cells and contribute to their leukemogenic transformation.
    Kong G; Du J; Liu Y; Meline B; Chang YI; Ranheim EA; Wang J; Zhang J
    J Biol Chem; 2013 Jun; 288(25):18219-27. PubMed ID: 23673656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. JAM3 maintains leukemia-initiating cell self-renewal through LRP5/AKT/β-catenin/CCND1 signaling.
    Zhang Y; Xia F; Liu X; Yu Z; Xie L; Liu L; Chen C; Jiang H; Hao X; He X; Zhang F; Gu H; Zhu J; Bai H; Zhang CC; Chen GQ; Zheng J
    J Clin Invest; 2018 May; 128(5):1737-1751. PubMed ID: 29584620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.